Institute of Physiology, Christian-Albrechts University of Kiel, 24118 Kiel, Germany.
Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Department of Structural Biology, 13125 Berlin, Germany.
Science. 2019 Feb 22;363(6429):875-880. doi: 10.1126/science.aav0569.
Potassium (K) channels have been evolutionarily tuned for activation by diverse biological stimuli, and pharmacological activation is thought to target these specific gating mechanisms. Here we report a class of negatively charged activators (NCAs) that bypass the specific mechanisms but act as master keys to open K channels gated at their selectivity filter (SF), including many two-pore domain K (K) channels, voltage-gated hERG (human ether-à-go-go-related gene) channels and calcium (Ca)-activated big-conductance potassium (BK)-type channels. Functional analysis, x-ray crystallography, and molecular dynamics simulations revealed that the NCAs bind to similar sites below the SF, increase pore and SF K occupancy, and open the filter gate. These results uncover an unrecognized polypharmacology among K channel activators and highlight a filter gating machinery that is conserved across different families of K channels with implications for rational drug design.
钾 (K) 通道已经进化为可以被多种生物刺激激活,而药理学激活被认为是针对这些特定的门控机制。在这里,我们报告了一类带负电荷的激活剂 (NCA),它们绕过特定的机制,但作为万能钥匙来打开其选择性过滤器 (SF) 门控的 K 通道,包括许多双孔域 K (K) 通道、电压门控 hERG (human ether-à-go-go-related gene) 通道和钙 (Ca) 激活的大电导钾 (BK)-型通道。功能分析、X 射线晶体学和分子动力学模拟表明,NCA 结合在 SF 以下的相似位点,增加了孔和 SF K 的占有率,并打开了过滤器门。这些结果揭示了 K 通道激活剂之间一种未被认识的多药理学,并强调了一种过滤器门控机制,该机制在不同家族的 K 通道中是保守的,这对合理药物设计具有重要意义。